Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 310

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 310
---
 West, Ste. 220

Houston, Texas 77070

 F-1 

ENDRA Life Sciences Inc.

Consolidated Balance Sheets

  December 31,  December 31, Assets 2024  2023 Current Assets      Cash $3,229,480  $2,833,907 Prepaid expenses  204,185   198,905 Total Current Assets  3,433,665   3,032,812 Non-Current Assets        Inventory  -   2,622,865 Fixed assets, net  69,281   111,782 Right of use assets  578,013   354,091 Prepaid expenses, long term  365,417   626,610 Other assets  5,986   5,986 Total Assets $4,452,362  $6,754,146          Liabilities and Stockholders’ Equity        Current Liabilities        Accounts payable and accrued liabilities $508,293  $700,754 Lease liabilities, current portion  96,937   173,857 Loans  -   28,484 Total Current Liabilities  605,230   903,095          Long Term Debt        Loans, long term  -   - Lease liabilities  487,482   192,062 Warrant Liability  799,284   - Total Long Term Debt  1,286,766   192,062          Total Liabilities  1,891,996   1,095,157          Stockholders’ Equity        Series A Convertible Preferred Stock, $0.0001 par value; 10,000 shares authorized; 17.488 and 141.397 shares issued and outstanding, respectively  -   1 Series B Convertible Preferred Stock, $0.0001 par value; 1,000 shares authorized; no shares issued and outstanding  -   - Series C Preferred Stock, $0.0001 par value; 100,000 shares authorized; no shares issued and outstanding  -   - Common stock, $0.0001 par value; 20,000,000 shares authorized; 536,908 and 5,937 shares issued and